MRI scans to predict how head and neck cancer will respond to treatment

This trial is testing a new type of MRI scan that looks for areas in head and neck tumors that don't have enough oxygen. Researchers believe these oxygen-poor areas may predict how well patients will respond to chemotherapy and radiation therapy. By identifying these patterns early, doctors hope to personalize treatment plans and improve outcomes.

Some head and neck cancers respond well to standard chemotherapy and radiation, while others don't — and doctors can't always predict which patients will benefit. This new imaging technique aims to identify which tumors are more likely to respond to treatment, so doctors can tailor therapy and potentially improve survival.